Alzamend Neuro (NASDAQ:ALZN) Issues Quarterly Earnings Results, Misses Estimates By $0.07 EPS
Alzamend Neuro (NASDAQ:ALZN – Get Free Report) released its quarterly earnings results on Wednesday. The company reported ($0.74) EPS for the quarter, missing analysts’ consensus estimates of ($0.67) by ($0.07), Zacks reports. Alzamend Neuro Stock Performance Shares of ALZN traded up $0.03 during trading hours on Wednesday, hitting $1.35. 70,780 shares of the stock were […]
22 Jul 22:42 · The Markets Daily